NEUP
Price
$7.83
Change
-$0.01 (-0.13%)
Updated
Aug 7, 10:39 AM (EDT)
Capitalization
14.74M
SLGL
Price
$13.62
Change
+$0.18 (+1.34%)
Updated
Aug 7, 10:30 AM (EDT)
Capitalization
37.44M
Earnings call today
Interact to see
Advertisement

NEUP vs SLGL

Header iconNEUP vs SLGL Comparison
Open Charts NEUP vs SLGLBanner chart's image
Neuphoria Therapeutics
Price$7.83
Change-$0.01 (-0.13%)
Volume$648
Capitalization14.74M
Sol-Gel Technologies
Price$13.62
Change+$0.18 (+1.34%)
Volume$184
Capitalization37.44M
NEUP vs SLGL Comparison Chart in %
Loading...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEUP vs. SLGL commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEUP is a Hold and SLGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (NEUP: $7.84 vs. SLGL: $13.44)
Brand notoriety: NEUP and SLGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEUP: 44% vs. SLGL: 39%
Market capitalization -- NEUP: $14.74M vs. SLGL: $37.44M
NEUP [@Biotechnology] is valued at $14.74M. SLGL’s [@Biotechnology] market capitalization is $37.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEUP’s FA Score shows that 1 FA rating(s) are green whileSLGL’s FA Score has 0 green FA rating(s).

  • NEUP’s FA Score: 1 green, 4 red.
  • SLGL’s FA Score: 0 green, 5 red.
According to our system of comparison, NEUP is a better buy in the long-term than SLGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEUP’s TA Score shows that 3 TA indicator(s) are bullish while SLGL’s TA Score has 6 bullish TA indicator(s).

  • NEUP’s TA Score: 3 bullish, 5 bearish.
  • SLGL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SLGL is a better buy in the short-term than NEUP.

Price Growth

NEUP (@Biotechnology) experienced а -3.92% price change this week, while SLGL (@Biotechnology) price change was +7.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.67%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

SLGL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLGL($37.4M) has a higher market cap than NEUP($14.7M). NEUP YTD gains are higher at: 128.571 vs. SLGL (44.501). NEUP has higher annual earnings (EBITDA): 192K vs. SLGL (-9.66M). NEUP (17M) and SLGL (16.9M) have equal amount of cash in the bank . NEUP has less debt than SLGL: NEUP (172K) vs SLGL (1.18M). NEUP has higher revenues than SLGL: NEUP (15.7M) vs SLGL (12.1M).
NEUPSLGLNEUP / SLGL
Capitalization14.7M37.4M39%
EBITDA192K-9.66M-2%
Gain YTD128.57144.501289%
P/E Ratio0.42N/A-
Revenue15.7M12.1M130%
Total Cash17M16.9M101%
Total Debt172K1.18M15%
FUNDAMENTALS RATINGS
SLGL: Fundamental Ratings
SLGL
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEUPSLGL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
89%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend about 1 month ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRFS3.560.10
+2.89%
BRF - Brasil Foods SA
SNAL1.020.02
+2.41%
Snail
DRTS3.120.05
+1.79%
Alpha Tau Medical Ltd
INTC20.410.22
+1.09%
Intel Corp
PMT11.97-0.11
-0.91%
PennyMac Mortgage Investment Trust

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
+3.29%
SYBX - NEUP
64%
Loosely correlated
-1.43%
BRNS - NEUP
50%
Loosely correlated
-5.07%
SLGL - NEUP
42%
Loosely correlated
-2.25%
CMND - NEUP
35%
Loosely correlated
-2.03%
ENSC - NEUP
31%
Poorly correlated
-4.93%
More

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
-2.25%
TRAW - SLGL
48%
Loosely correlated
-0.65%
NEUP - SLGL
41%
Loosely correlated
+3.29%
RAPT - SLGL
39%
Loosely correlated
-1.09%
GTBP - SLGL
33%
Poorly correlated
-1.69%
CMND - SLGL
32%
Poorly correlated
-2.03%
More